Doctors hear about new guidelines for treating hypertrophic cardiomyopathy

1st June 2015

More than 150 cardiologists and specialist heart nurses attended our annual medical conference in London on Friday.

Top cardiomyopathy experts from around Europe talked about the latest guidelines on treating hypertrophic cardiomyopathy, and how the guidance could be implemented in heart clinics to the benefit of patients.

medical conference

The guidelines have been produced by the European Society of Cardiology (ESC), and experts on the group were well represented among the day’s speakers.

The new guidelines focus on the need for a multidisciplinary approach to HCM, including imaging, genetics, surgical interventions, heart devices, and drug treatments. So the day looked at the different causes of HCM and their implications for diagnosis, the role of echo, genetic counselling and testing, managing symptoms, implications of risk for a cardiac arrest, contraception, pregnancy and lifestyle advice.

Medical director of Cardiomyopathy UK, Robert Hall, said: “Our medical conferences provide a detailed understanding of cardiomyopathy and best practice in treating it, and are key to helping patients get better care.  The new guidelines for treating HCM are a very important step forward.

The speakers at the conference included Cardiomyopathy UK vice president Professor Perry Elliott, Professor Albert Hagege from the Georges Pompidou Hospital, France; Dr Claudio Rapezzi from the University of Bologna, Italy; and Dr Els Pieper from the University Medical Centre, Groningen, Netherlands..

The conference, at the Cavendish Conference in Duchess Mews was endorsed by heart care leaders the British Cardiovascular Society and the ESC. Trainee medical grades had free places and consultants paid a discounted rate of £95.

For more details about our forthcoming medical conferences, see here.